Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors
NCT06553365
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Nerve Sheath Tumor
Interventions
DRUG:
FCN-159
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences